Brief: Gentian Diagnostics Q1 EBITDA Loss Narrows To NOK 0.5 Mln
05/05/2023 06:43
May 5 (Reuters) - Gentian Diagnostics ASA GENT.OL :
* Q1 RECORD SALES OF MNOK 31.4, UP 53% FROM 1Q22, WITH
ORGANIC
GROWTH OF 40%
* Q1 EBITDA WAS MNOK -0.5 IN 1Q23 VERSUS MNOK -4.2 IN 1Q22
Source text for Eikon: ID:nObikRcxna
Further company coverage: GENT.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership
Brief: Gentian Diagnostics Renews Long-Term Partnership With Bühlmann Laboratories
Brief: Gentian Diagnostics Q4 EBITDA NOK 10.5 Million
Brief: Gentian Diagnostics Enters Exclusive Agreement With Global Diagnostics Company